A new study is showing a policy change in 2016 related to the vaccination of some premature babies for RSV in Nova Scotia led to a tenfold increase in the number of infants in that group that were ...
This came after AstraZeneca presented the proposal to conduct a Phase IV clinical trial titled “A Multicentre, Interventional, Phase IV, Open-label Study to Evaluate the Safety of Palivizumab in ...
mAbxience is headquartered in Madrid, Spain. For a complete picture of Palivizumab biosimilar’s drug-specific PTSR and LoA scores, buy the report here. GlobalData, the leading provider of industry ...
We also show that treatment of LoM with a small molecule antiviral (ribavirin) or a neutralizing antibody (palivizumab) significantly suppressed and/or prevented RSV infection in vivo. Our data ...
Objective To evaluate the effectiveness of two palivizumab programmes targeting high-risk infants, defined by prematurity, diagnosis of comorbidities and geography, and assess potential disparities by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results